参考文献/References:
[1] 中国医师协会风湿免疫科医师分会,中华医学会风湿病学分会,中华医学会骨质疏松和骨矿盐疾病分会,等.2020版中国糖皮质激素性骨质疏松症防治专家共识[J].中华内科杂志,2021,60(1):13-21.
[2] 中华医学会骨质疏松和骨矿盐疾病分会.原发性骨质疏松症诊治指南(2011年)[J].中华骨质疏松和骨矿盐疾病杂志,2011,4(1):2-17.
[3] 荆楠,刘力畅,野炳钊,等.阿仑膦酸钠对绝经后骨质疏松合并骨关节炎患者骨强度的影响[J].中国骨质疏松杂志,2021,27(1):119-122.
[4] 张华果,宋咪,徐月,等.老年骨质疏松性骨折再发的研究进展[J].中国全科医学,2021,24(7):886-889.
[5] 余琴,刘迅,邢莎莎,等.红景天苷在疾病中的作用及机制研究进展[J].中国药师,2020,23(3):526-529.
[6] 冯闯,左中夫,刘文强,等.红景天苷对糖尿病早期大鼠视网膜Müller细胞的保护作用[J].中国中医基础医学杂志,2020,26(5):609-612.
[7] SU Y,LEUNG J,KWOK T.The role of previous falls in major osteoporotic fracture prediction in conjunction with FRAX in older Chinese men and women:the Mr.OS and Ms.OS cohort study in Hong Kong[J].Osteoporosis Int,2018,29(6):1469.
[8] HARVEY N C,ODEN A,ORWOLL E,et al.Falls predict fractures independently of FRAX probability:a meta-analysis of the osteoporotic fractures in men(MrOS)study[J].J Bone Miner Res,2018,33(3):510-516.
[9] MOCKEL L,BARTNECK M,MOCKEL C.Risk of falls in postmenopausal women treated with romosozumab:preliminary indices from a meta-analysis of randomized,controlled trials[J].Osteoporos Sarcopenia,2020,6(1):20-26.
[10] BONACCORSI G,PIVA I,GRECO P,et al.Oxidativessa post-menopausal osteoporosis:existing vision support of the axisis oestrogen defciency-redox imbalance-boneloss[J].India J MedRes,2018,147(4):341.
[11] QIAO W,YU S,SUN H,et al.1,25-dihydroxyvitamin D insufficiency accelerates age-related bone loss by increasing oxidative stress and cell senescence[J].Am J Transl Res,2020,12(2):507-518.
[12] 张申尧,董克芳,王凡.红景天苷抵抗骨细胞凋亡的作用和对绝经后骨质疏松患者的影响[J].中国临床药理学杂志,2020,36(22):3624-3629.
[13] 崔雅妹,穆超超,李书宁,等.红景天临床应用概况[J].实用中医内科杂志,2019,33(4):74-77.
[14] ZHANG P,ZHANG H,LIN J,et al.Insulin impedes osteogenesis of BMSCs by inhibiting autophagy and promoting premature senescence via the TGF-β1 pathway[J].Aging(Albany,NY),2020,12(3):2084-2100.
[15] BUCKLEY L,HUMPHREY M B.Glucocorticoid induced osteoporosis[J].N Engl J Med,2018,379(26):25472556.
[16] 陈光华,黄贵芝,林颢,等.骨髓间充质干细胞移植对去卵巢骨质疏松大鼠骨密度的影响[J].中国组织工程研究,2017,21(1):49-53.
[17] ZHANG J K,YANG L,MENG G L,et al.Protection by salidroside against bone loss via inhibition of oxidative stress and bone-resorbing mediators[J].PLoS One,2013,8(2):e57251.
[18] LING L,YE Q,XIN J,et al.Protective effect of salidroside against bone loss via hypoxia-inducible factor-1α pathway-induced angiogenesis[J].Sci Rep,2016,6:32131.